Bachem (OTCMKTS:BCHMF) vs. Huntsman (NYSE:HUN) Head-To-Head Comparison

Bachem (OTCMKTS:BCHMFGet Free Report) and Huntsman (NYSE:HUNGet Free Report) are both basic materials companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, dividends, risk, valuation, profitability, analyst recommendations and institutional ownership.

Analyst Recommendations

This is a summary of current ratings and target prices for Bachem and Huntsman, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Bachem 2 0 0 0 1.00
Huntsman 2 11 2 0 2.00

Huntsman has a consensus target price of $28.42, indicating a potential upside of 12.90%. Given Huntsman’s stronger consensus rating and higher probable upside, analysts clearly believe Huntsman is more favorable than Bachem.


This table compares Bachem and Huntsman’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Bachem N/A N/A N/A
Huntsman 2.64% 5.75% 2.84%

Insider and Institutional Ownership

83.4% of Huntsman shares are held by institutional investors. 5.6% of Huntsman shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Earnings & Valuation

This table compares Bachem and Huntsman’s revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Bachem N/A N/A N/A N/A N/A
Huntsman $6.86 billion 0.65 $460.00 million $0.96 26.22

Huntsman has higher revenue and earnings than Bachem.


Huntsman beats Bachem on 9 of the 9 factors compared between the two stocks.

About Bachem

(Get Free Report)

Bachem Holding AG, together with its subsidiaries, provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide. The company engages in the development, production, and regulatory support of peptide active pharmaceutical ingredients, such as peptide and oligonucleotide new chemical entities (NCEs). It also offers commercial NCEs and generics; and project management, quality and regulatory, analytical, good manufacturing practice production, research grade production, and supply and vertical integration services. The company was founded in 1971 and is headquartered in Bubendorf, Switzerland.

About Huntsman

(Get Free Report)

Huntsman Corporation manufactures and sells diversified organic chemical products worldwide. The company operates through three segments: Polyurethanes, Performance Products, and Advanced Materials. The Polyurethanes segment offers polyurethane chemicals, including methyl diphenyl diisocyanate, polyether and polyester polyols, and thermoplastic polyurethane. The Performance Products segment manufactures amines and maleic anhydrides. The Advanced Materials segment offers epoxy, phenoxy, acrylic, polyurethane, and acrylonitrile-butadiene-based polymer formulations; and high performance thermoset resins, curing and toughening agents, and carbon nanotubes additives. The company's products are used in a range of applications, including adhesives, aerospace, automotive, construction products, durable and non-durable consumer products, electronics, insulation, medical, packaging, coatings and construction, power generation, and refining. Huntsman Corporation was founded in 1970 and is based in The Woodlands, Texas.

Receive News & Ratings for Bachem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bachem and related companies with's FREE daily email newsletter.